Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2018-09-10 2018-09-10
Drug Identification Number 02240434 02240434
Brand name FENTANYL CITRATE INJECTION USP FENTANYL CITRATE INJECTION USP
Common or Proper name FENTANYL FENTANYL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients FENTANYL FENTANYL
Strength(s) 50MCG 50MCG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS EPIDURAL INTRAMUSCULAR INTRAVENOUS EPIDURAL
Packaging size 10 X 2ML AMPOULES 10 X 2ML AMPOULES
ATC code N01AH N01AH
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-08-17 2018-08-17
Estimated end date 2018-09-03 2018-09-03
Actual end date 2018-09-03 2018-09-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments